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In a previous study from this laboratory it was 
shown that mitochondria can be harvested from 
rat small intestinal epithelial cells and that these 
mitochondria show intact oxidative phosphoryla- 
tion [ 11. Further studies [2] showed that the iso- 
lated mitochondria are able to oxidize octanoate 
and palmitate completely to CO? and HzO, where- 
as earlier studies [3] showed that 3-hydroxybuty 
rate is also a substrate for these mitochondria. It 
is the purpose of the present paper to extend these 
studies with observations carried out with isolated 
rat small intestine, perfused in vitro with glucose 
and/or long-chain fatty acids, octanoate or 3-hydroxy- 
butyrate. 
The present experiments are carried out with 
small intestines isolated from fed male white rats 
(250-300 g). The animals were operated under 
Nembutal narcosis. The operation was carried out 
in principle as described by Gerber [4] . The rectum 
was cut between two ligatures and mobilized, fol- 
lowed by a complete coecum and large bowel re- 
section. The duodenum was opened about 5 cm 
from the stomach and a cannula inserted so that the 
small intestine could be rinsed with 50 ml warm 
saline. After the passage of air the duodenum and 
the terminal ileum were tied. The abdominal aorta 
was prepared free from the A. coeliaca until the 
bifurcatio iliaca. Loose ligatures were placed around 
the aorta, distal and proximal from the A. mesen- 
terica superior, whereas the A. renalis dextra was 
tied. Loose ligatures were also placed under the V. 
porta and the V. mesenterica superior, after tying 
the V. gastricuduodenalis and V. lienalis. Then the 
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aorta was cannulated with a needle (Brauntile, size 
0.5 R; Braun, Melsungen, Germany) a little above 
the bifurcatio iliaca and the needle tip moved up- 
wards until the A. mesenterica superior was reached. 
The cannula was fixed by tying the loose distal 
ligature. The ligature around the aorta proximal of 
the A. mesenterica superior was tied and the per- 
fusion was started at a rate of 4 ml per min. The 
portal vein was opened as close to the liver as pos- 
sible with another needle (Brauntile, size 1 R) and 
the tip of the cannula pushed away from the liver 
and fixed with the ligatures. The whole preparation 
was removed from the rat and placed on a perspex ’ 
disc of the apparatus designed for liver perfusion 
by Scholz [5]. The perfusion rate was increased to 
8 ml/min after a “zero time” sample of the perfu- 
sion medium was collected. During the cannulation, 
the rat’s own blood was removed from the prepa- 
ration by perfusion with about 20 ml “artificial” 
perfusion medium prior to recirculation was started. 
The perfusion volume amounted to 67 f 14 ml and 
the temperature was 33 + 2”. The perfusion medium 
was essentially according to Forth [6] , consisting, 
in addition to the substrate to be specified, of Krebs- 
Henseleit [7] bicarbonate buffer (pH 7.4) with 5.6% 
polyvinyl pyrrolidone (M.W. 25,000-30,000) 3.4% 
fatty acid-poor bovine serum albumin (Pentex), 
2 X washed human erythrocytes (hematocrit finally 
about 20%) 10 mg% papaverin, 4 mg % heparin and 
4 mg % promethazin. Perfusion was terminated after 
1 hr, the perfusion volume measured and a sample 
taken for analysis. 
It can be seen from table 1 that glucose, long-chain 
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Table 1 
Substrates for rat small intestinal metabolism during 
(vascular) in vitro perfusion. 
Substrate added Substrate Theoretical 
used maximal rate 
of ATP for- 
mationa 
(fimole/hr) (pmole/hr) 
5.2 mM glucose 
0.36 mM 1-14C-palmitate 
1lOb 1480 
(1 MM = 0.015 &i) 
1.0 mM 1-t4C-palmitate 
3.8 490 
(1 PM = 0.01 rCi) 
2.0 mM l-14C-octanoate 
12.1 1561 
(1 PM = 0.004 r.Ki) 
5.4 mM D(-)3-hydroxy- 
20.6 1257 
butyrate 42.6’ 912 
a Assuming a P:O ratio of 3 for NADH oxidation. 
b 75 bmole converted into lactate, since 150 pmole of lactate 
accumulated. 
’ In this experiment he rate of acetoacetate accumulation 
was 8.5 Mmole/hr. 
Perfusiontime 1 hr. Glucose, lactate, D(-)3-hydroxybutyrate 
and acetoacetate were determined in HC104-deproteinized 
and subsequently neutralized samples enzymatically, as 
shown in [ 8- 111, respectively. Palmitate and octanoate 
disappearance was calculated from the radioactivity disap 
peared during perfusion. For these radioactivity measurc- 
ments samples of the perfusionmedium, after centrifugation, 
were measured by liquid scintillation counting as described 
by Patterson and Greene [121. 
and medium-chain fatty acids may be good substrates 
for metabolism. Low concentrations of palmitate are 
not well extracted, whereas D(-)3-hydroxybutyrate 
takes an intermediate position. In experiments with 
3-r4C-DL-3-hydroxybutyrate (not shown) it was 
found that the percentage of radioactivity removed 
during perfusion was about twice as high as the per- 
centage of D(-)3-hydroxybutyrate disappeared, in- 
dicating the utilization of L(+)3-hydroxybutyrate. 
This compound could be activated in the medium- 
chain fatty acyl-CoA synthetase reaction [ 131, prior 
to complete oxidation. 
From table 2 it can be seen that, at least under 
the conditions of the test, glucose catabolism is not 
clearly influenced by continuous insulin addition. 
The animals were pretreated with mannoheptulose 
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to ensure a low endogenous insulin concentration 
prior to operation. From these 4 experiments it 
appears that as an average, 7 1.2% of the glucose re- 
moved was converted to lactate and that as much 
as 28.8% was probably completely oxidized. This 
situation changes when together with glucose, oleate 
or octanoate are added to the perfusion medium 
(table 2). Now 95.8% (average) of the glucose is 
converted to lactate and only 4.2% is completely 
oxidized. From the measurement of the oleate or 
octanoate disappearance (corrected for the small 
amount accumulated in the intestine after perfusion, 
as measured in the homogenized tissue) it must be 
concluded that oleate or octanoate oxidation yield 
the bulk of the energy. It appears then that in small 
intestine during fatty acid oxidation, pyruvate oxi- 
dation is inhibited. For the possible mechanism of 
this inhibition, we refer to the work of Garland et al. 
[ 141, who concluded from their studies on pyruvate 
metabolism in muscle that inhibition of pyruvate de- 
hydrogenase may be caused by high acetyl-CoA/CoA 
and NADH/NAD’ ratios, and to a possible inactiva- 
tion of pyruvate dehydrogenase as described by Linn 
et al. [ 151 and Wieland and Jagow-Westermann [ 161 
in other tissues than intestine. 
These present data are in agreement with other 
tissues in which fatty acids are also a preferred sub- 
strate when compared with glucose. However, under 
the present conditions glycolysis is not inhibited 
while fatty acids are oxidized (table 2). Maybe that 
here hexokinase is the rate-limiting step and not the 
phosphofructokinase or pyruvate kinase reaction 
(although pyruvate kinase has been found to be of 
the Liver-type as judged by the allosteric stimula- 
tion by fructose-l ,6-P, ; results not shown). Srivastava 
and Hubscher [ 17 j indeed observed that hexokinase 
in homogenates of small intestine is the enzyme 
which limits the rate of glycolysis. 
Although the rate glycolysis is increased in dia- 
betes [ 181, insulin is probably not directly in- 
fluencing this process. In the first place we find 
no effect of insulin (table 2) during in uifro perfusion 
and in the second place diabetes and not fasting 
(both conditions with low insulin levels in the blood) 
causes an increased rate of glycolysis [ 181 . It is 
possible that not only glucose-feeding, after a period 
of fasting, increases soluble intestinal hexokinase 
[ 19, 201, by a release from particle-bound hexokinase 
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Influence of insulin and fatty acids on glucose metabolism of in vitro perfused rat small intestine. 
Pretreatment 
of rat 
Addition to perfusion medium Glucose 
used 
Lactate 
formed 
(rmole/hr) 
Fatty acid 
removed 
Mannoheptulosea 5.2 mM glucose 96 140 - 
Mannoheptulosea 5.2 mM glucose 98 141 - 
Mannoheptulosea 10 U insulin + 5.2 mM glucose 111 158.5 _ 
Mannoheptulosea 8.7 U insulin + 5.2 mM glucose 93 128 _ 
None 1.3 mM l-14C-oleateb + 5.2 mM glucose 93.5 179 1.4 
None 1.2 mM l-14C-oleateb + 5.2 mM glucose 115 225 7.1 
None 2 mM l-‘4C-octanoatec + 8.3 mM glucose 170 330 28.1 
None 2 mM l-‘4C-octanoatec + 8.3 mM glucose 149 277 23.9 
a 200 mg mannoheptulose (a gift from Schering A.G. Berlin, which is gratefully acknowledged) was injected intraperitoneally 
b 
2 hr prior to operation. 
1 PM 0.006 PCi. = 
c 1 PM = 0.004 &i. 
[21 J mainly bound in the brush-border region of 
the epithelial cells [22], but also hyperglycemia 
per se. That hexokinase activity in intestinal mu- 
cosa indeed rises in diabetes has been shown ear- 
lier [23]. Anderson and Zakim [24] recently de- 
scribed that alloxan-diabetes, in contrast to fast- 
ing, in rats causes no reduction of jejunal hexoki- 
nase and pyruvate kinase. 
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